TTI-101
SM_CP2016-0842
Phase 1 small_molecule completed
Quick answer
TTI-101 for Breast Cancer is a Phase 1 program (small_molecule) at Tvardi Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Tvardi Therapeutics
- Indication
- Breast Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed